Vanguard Global Advisers
ELV icon

Vanguard Global Advisers’s Elevance Health ELV Stock Holding History

Vanguard Global Advisers’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$184M Sell
474,890
-25,765
-5% -$9.56M 0.09% 162
2026
Q1 		$147M Buy
+500,655
New +$165M 0.08% 202

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Vanguard Global Advisers's ELV Position: Q2 2026 in Review

Vanguard Global Advisers reduced its Elevance Health (ELV) stake by 5.1% in Q2 2026, selling an estimated $9.56M and leaving 474,890 shares worth $184M. The position accounts for 0.09% of the portfolio, ranked #162.

Vanguard Global Advisers first reported a position in ELV in Q1 2026 and has held it in 2 quarters since. 1,513 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Vanguard Global Advisers held 474,890 shares of Elevance Health worth $184M as of Q2 2026.
  • Vanguard Global Advisers sold 25,765 Elevance Health shares in Q2 2026, an estimated $9.56M.
  • Elevance Health made up 0.09% of Vanguard Global Advisers's portfolio in Q2 2026, its #162 holding.
  • Vanguard Global Advisers first reported a position in Elevance Health in Q1 2026 and has held it in 2 quarters since.
  • 1,513 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.